In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

CV biomarkers in COVID-19

ACVC Biomarker Talk Series

19/05/2021 18:00 19/05/2021 18:30 Europe/Paris CV biomarkers in COVID-19

Access event page

Association for Acute CardioVascular Care DD/MM/YYYY
Association for Acute CardioVascular Care
Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care

Focus on

  Discover the ACVC Biomarker Talk Series

A series of 12 concise and interactive online sessions on biomarkers, covering the full spectrum of the topic. Each talk will be followed by an editorial article published in the EHJ-ACVC on the topic.


Learning objectives

After watching this webinar, participants will be able to:

  • identify clinical and laboratory variables associated with a high risk of death and/or the need for mechanical ventilation;
  • understand that cardiomyocyte injury and (sub)clinical heart failure are the most frequent cardiac complications in COVID-19;
  • appreciate that high sensitivity cardiac troponin and natriuretic peptides are strongly associated with death and/or need for ICU admission and may help clinicians; and
  • know that novel biomarkers g. GDF-15) also may have value, but need further study.